Interactive, Live Virtual Webinar

Tuesday, March 11, 2025

Target Audience

This activity is intended for physicians, physician assistants/associates, and nurses engaged in the care of patients with hematologic malignancies.

Educational Objectives

After completing this activity, the participant should be better able to:

• Describe the underlying science and mechanisms of bispecific therapies
• Identify current and emerging indications for bispecific therapies for hematologic malignancies
• Assess the clinical evidence on the efficacy, safety, and potential side effects of bispecific therapies
• Develop strategies for incorporating bispecific therapies into clinical practice
• Describe the treatment process and mechanisms to improve patient understanding, care, and involvement
• Discuss challenges and potential future advancements in bispecific antibody development

Faculty

This activity is jointly provided by The Leukemia & Lymphoma Society and Postgraduate Institute for Medicine.

There is no commercial support associated with this activity.

For questions, concerns, or assistance for people with disabilities or grievances, please contact us at: profeducation@LLS.org.